CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,971 | -59.0% | 24,983 | -30.9% | 0.00% | – |
| Q2 2023 | $102,300 | -46.3% | 36,148 | -6.8% | 0.00% | – |
| Q1 2023 | $190,514 | -70.7% | 38,801 | -35.8% | 0.00% | – |
| Q4 2022 | $649,490 | +351.0% | 60,474 | +292.2% | 0.00% | – |
| Q3 2022 | $144,000 | +60.0% | 15,419 | +57.2% | 0.00% | – |
| Q2 2022 | $90,000 | -53.1% | 9,806 | -37.9% | 0.00% | – |
| Q1 2022 | $192,000 | -57.5% | 15,781 | -57.5% | 0.00% | – |
| Q4 2021 | $452,000 | +128.3% | 37,165 | +189.9% | 0.00% | – |
| Q3 2021 | $198,000 | -37.5% | 12,818 | -42.2% | 0.00% | – |
| Q2 2021 | $317,000 | -22.3% | 22,176 | +17.9% | 0.00% | – |
| Q1 2021 | $408,000 | -2.6% | 18,808 | -32.2% | 0.00% | – |
| Q4 2020 | $419,000 | +59.9% | 27,725 | +34.3% | 0.00% | – |
| Q3 2020 | $262,000 | -54.1% | 20,646 | -38.2% | 0.00% | – |
| Q2 2020 | $571,000 | +6.1% | 33,389 | -17.9% | 0.00% | – |
| Q1 2020 | $538,000 | -59.9% | 40,677 | -51.2% | 0.00% | – |
| Q4 2019 | $1,343,000 | +32.3% | 83,386 | +50.2% | 0.00% | – |
| Q3 2019 | $1,015,000 | -47.0% | 55,518 | -37.7% | 0.00% | -100.0% |
| Q2 2019 | $1,916,000 | +46.1% | 89,147 | +33.5% | 0.00% | 0.0% |
| Q1 2019 | $1,311,000 | -50.4% | 66,789 | -67.2% | 0.00% | 0.0% |
| Q4 2018 | $2,644,000 | +71.0% | 203,457 | +215.2% | 0.00% | 0.0% |
| Q3 2018 | $1,546,000 | +365.7% | 64,553 | +273.3% | 0.00% | – |
| Q2 2018 | $332,000 | -85.0% | 17,294 | -90.3% | 0.00% | -100.0% |
| Q1 2018 | $2,207,000 | +364.6% | 178,260 | +359.1% | 0.00% | – |
| Q4 2017 | $475,000 | -68.7% | 38,824 | -65.0% | 0.00% | -100.0% |
| Q3 2017 | $1,519,000 | +3.8% | 110,954 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $1,463,000 | +654.1% | 95,073 | +801.7% | 0.00% | – |
| Q1 2017 | $194,000 | +131.0% | 10,544 | +16.9% | 0.00% | – |
| Q4 2016 | $84,000 | +833.3% | 9,016 | +758.7% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 1,050 | -58.0% | 0.00% | – |
| Q2 2016 | $12,000 | +300.0% | 2,498 | +399.6% | 0.00% | – |
| Q1 2016 | $3,000 | -92.7% | 500 | -79.4% | 0.00% | – |
| Q4 2015 | $41,000 | -25.5% | 2,431 | -36.5% | 0.00% | – |
| Q3 2015 | $55,000 | +161.9% | 3,826 | +123.0% | 0.00% | – |
| Q2 2015 | $21,000 | +320.0% | 1,716 | +243.2% | 0.00% | – |
| Q1 2015 | $5,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |